Viral Safety of Plasma-derived Blood Products. II. Effect of Virus Elimination by Nanofiltration Using PLANOVA35N on Monoclonalpurified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M) and Intramascular Human Immunoglobulin (Anti-HBs Human immune Globulin "Nisseki" and Human Immune Globulin "Nisseki").